Povidone-Iodine Oral Rinse Study
Not Recruiting
18-100 years
All
Phase
2
40 participants needed
1 Location
Brief description of study
The purpose of this study is to evaluate the effect of an antiseptic mouthwash solution compared to a placebo mouthwash (has no therapeutic effect) on reducing SARS-CoV-2 virus in the mouth of people who are currently COVID-19+. The study will test whether or not a mouthwash solution will reduce the amount of virus in the mouth.
Detailed description of study
Phase I of the study consists of attending 1 study visit (about 1.5 hours). At this visit, participants will be confirmed eligible, provide samples (oral swab and saliva sample), and complete an oral health questionnaire.
Phase II of the study consists of using an antiseptic mouth rinse for one week and attending a remote follow-up visit.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Covid-19
-
Age: Between 18 Years - 100 Years
-
Gender: All
- Eligible participants will be:
- Enrolled within 5 days of a positive COVID-19 test (and test positive for COVID-19 during the study visit)
- Present with at least one COVID-19 symptoms (for example, fever, cough, shortness of breath, nausea, fatigue, chills, sore throat, headache, congestion/runny nose, new loss of taste or smell, or muscle aches).
Updated on
01 Aug 2024.
Study ID: 849386
